Tvaster Genkalp
Similar Companies Hiring
Tvaster Genkalp is a Molecular Diagnostics company, established in May 2021, specialising in Liquid Biopsy, offering blood based cancer diagnostic solutions. With innovative approach and commitment to quality, Tvaster has developed a groundbreaking screening test for Hepatocellular carcinoma (HCC) called Episcreen™ Liver.
Episcreen™ Liver represents a major leap forward in the early detection of liver cancer (HCC). Rigorously validated through a study involving over 750 patients, this technology has demonstrated exceptional accuracy, far surpassing the current standard blood-based biomarker, AFP. The recent clinical study revealed that Episcreen™ Liver achieved an impressive sensitivity of 90%, in stark contrast to AFP’s 50%. Moreover, Episcreen™ Liver identified 92% of HCC cases missed by AFP, offering a potentially life-saving solution for countless individuals.
Tvaster is dedicated to enhancing early cancer detection and improving patient outcomes through its state-of-the-art diagnostic solutions.
Episcreen™ Liver represents a major leap forward in the early detection of liver cancer (HCC). Rigorously validated through a study involving over 750 patients, this technology has demonstrated exceptional accuracy, far surpassing the current standard blood-based biomarker, AFP. The recent clinical study revealed that Episcreen™ Liver achieved an impressive sensitivity of 90%, in stark contrast to AFP’s 50%. Moreover, Episcreen™ Liver identified 92% of HCC cases missed by AFP, offering a potentially life-saving solution for countless individuals.
Tvaster is dedicated to enhancing early cancer detection and improving patient outcomes through its state-of-the-art diagnostic solutions.
Tvaster Genkalp Offices
OnSite Workspace
Employees work from physical offices.
Typical time on-site:
None
Chennai, Tamil Nadu, IND
